Clinical trials for MTBVAC, a novel tuberculosis (TB) vaccine developed by Bharat Biotech and Biofabri, have commenced in India. The initial results show promise in preventing the disease. The collaboration between the two companies aims to develop an effective TB vaccine that can address the global burden of the disease.